Featured NRHA Partners
340B Drug Pricing Program & Pharmacy
The 340B Drug Pricing Program is a lifeline that allows rural safety net providers to stretch scarce federal resources and keep their doors open to provide vital services to their communities. Significant 340B Program restrictions by manufacturers and pharmaceutical benefit managers (PBMs) are hurting already struggling hospitals and clinics. We encourage you to utilize the following advocacy materials and external resources when you are advocating for the 340B Drug Pricing Program!
Advocacy Materials
Rural 340B Drug Pricing Program Priorities legislative leave behind
Advocacy Campaign
Relevant NRHA Policy Papers
Relevant NRHA Public Comments
- Letter to Congressional Leadership on J&J Rebate Model
- Response to Senate 340B request for information
- Letter to Sectary Becerra on 340B Drug Pricing Program
- Letter HHS Secretary on 340B Drug Pricing Program
- Letter to Senate HELP & Appropriations on 340B Extender
- OPPS Remedy for the 340B-Acquired Drugs Payment Policy for CYs 2018 - 2022
- OPPS 340B Remedy proposed rule (member comment template)
- HRSA 340B Administrative Dispute Resolution proposed rule
- FTC Solicitation for Public Comments on Pharmacy Benefit Managers Business Practices
- 340B Extender Letter to Rep. McMorris Rodgers, Pallone, Granger, and DeLauro
- 340B Final Letter to Sen. Sanders, Cassidy, Murray, and Collins
- Response to SUSTAIN 340B Act RFI